Alzheimer's Disease Trial, Recruiting NCT07367880 Sponsor: University Hospital, Grenoble Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Recruiting

NCT07367880
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people with Alzheimer's disease:

  • People aged 50 or older who have been diagnosed with possible or probable Alzheimer's disease (based on recognised 2011 diagnostic guidelines)
  • People whose score on a standard memory and thinking test (called the MMSE) falls between 18 and 26 out of 30

For people joining as healthy comparison participants (controls):

  • People aged 50 or older
  • People whose MMSE score is 26 or above, indicating no significant memory or thinking difficulties

For everyone:

  • Participation requires that the person has no objection to taking part in the trial

Who may not be able to join:

For people with Alzheimer's disease:

  • People who fall under certain protected legal categories under French public health law (Articles L1121-5 to L1121-8 of the French Code de la Santé Publique — confirm with trial site for details)

For people joining as healthy comparison participants (controls):

  • People who have memory complaints
  • People who fall under the same protected legal categories mentioned above (confirm with trial site)

For everyone:

  • People with a significant history of neurological or psychiatric conditions
  • People currently taking certain psychiatric medications, specifically antipsychotics (neuroleptics)
  • People who do not have a sufficient command of the French language or who have difficulties with comprehension
  • People with significant hearing or vision problems (such as double vision, involuntary eye movements, or blind spots in vision)
  • People with limited exposure to media or general cultural knowledge, as assessed by a questionnaire
  • People who have difficulty recognising faces, as measured by a standard test called the Benton Face Recognition Test

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +334.76.76.57.90

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
23 February 2026
Est. completion
1 February 2031

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Difference between the two groups in the identification and naming task involving famous landmarks

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov